Trial intelligence / Profile preview

Adrenaline Concentration in Tumescence Solution for Liposuction

NCT05822765Phase 3Completed

Sponsor
Al-Azhar University
Start
May 2023
Primary completion
Oct 2023
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of epinephrine, sponsored by Al-Azhar University. Started May 2023; status: completed.

02

Drugs

epinephrine

Beyond the preview

Go deeper on NCT05822765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05822765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call